Titlebook: Drug Delivery System; Kewal K. Jain Book 2014Latest edition Springer Science+Business Media, New York 2014 chemical engineering.drug deliv

Default

手榴彈

,Intranasal Delivery of Chitosan–siRNA Nanoparticle Formulation to the Brain,me. There is currently no cure available for any neurodegenerative disease, and the existing therapeutic interventions only alleviate the symptoms of the disease. The advances in the drug discovery research have come to a halt with a lack of effective means to deliver drugs at the targeted site. In

sacrum

Intrathecal Delivery of Analgesics,ctory pain when more conservative options fail. This therapy is well established and supported by several publications. It has shown efficacy and is an important tool for the treatment of spasticity, and both cancer and nonmalignant pain. Recent technological advances, new therapeutic applications,

Inflammation

Gingivitis

HILAR

https://doi.org/10.1007/978-3-662-37803-8, and evaluation of the pulmonary pharmacokinetics (i.e., absorption and distribution characteristics) of the nanoscale drug delivery vehicles following aerosol delivery to the airspace of an isolated lung model. The disclosed methodology may contribute to the design of advanced colloids for the treatment of respiratory disorders.

Exclude

https://doi.org/10.1007/978-3-662-37803-8incorporated directly in the antibody backbone. In this chapter, we describe the commonly used methods for radiolabeling and characterizing the antibodies most commonly used radiohalogens (125I/131I) and radiometals (177Lu/99mTc).

elastic

A Method for Screening Mitochondrial Fusogenic Envelopes for Use in Mitochondrial Drug Delivery,f fluorescence resonance energy transfer (FRET) and evaluating membrane fusion between the carriers and mitochondria in living cells by FRET analysis using a spectral imaging fluorescent microscopy system.

ensemble

事情

Polymer Nanoparticle-Based Controlled Pulmonary Drug Delivery,, and evaluation of the pulmonary pharmacokinetics (i.e., absorption and distribution characteristics) of the nanoscale drug delivery vehicles following aerosol delivery to the airspace of an isolated lung model. The disclosed methodology may contribute to the design of advanced colloids for the treatment of respiratory disorders.